Arrowhead Pharmaceuticals (ARWR) Peer Comparison

$47.78

up-down-arrow $0.63 (1.34%)

As on 13-Nov-2026 16:06EST

Market cap

info icon

$6,749 Mln

Revenue (TTM)

info icon

$451 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

14.3

Div. Yield

info icon

0 %

Edit peer-selector-edit
Arrowhead Pharmaceuticals (ARWR) Exelixis (EXEL) Ascendis Pharma A/S - ADR Halozyme Therapeutics (HALO) Kymera Therapeutics (KYMR)
Market cap ($ Mln)
6,749 16,837 18,064 11,432 10,891
Revenue ($ Mln)
451 2,497 1,208 1,802 102
Net Profit ($ Mln)
-724.21 885.14 890.37 485.42 -349.47
Net Margin (%)
-160.64 35.45 73.69 26.93 -341.87
RoE (%)
-280.50 46.96 88.40 -- -22.16
Price to Earnings
-- 20.66 18.11 25.19 --
Price-To-Book
14.31 9.18 10.44 97.15 6.72

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month